A comparative study of PF‐06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgroup analysis

AIM: PF‐06438179/GP1111 (PF‐SZ‐IFX) is a biosimilar of reference infliximab (Remicade(®)). This analysis compared the efficacy of PF‐SZ‐IFX and reference infliximab sourced from the European Union (IFX‐EU) in patient subgroups from a randomized, comparative study of PF‐SZ‐IFX versus IFX‐EU. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kameda, Hideto, Uechi, Eishi, Atsumi, Tatsuya, Abud‐Mendoza, Carlos, Kamei, Kazumasa, Matsumoto, Tsugumi, Ponce de Leon, Dario, Rehman, Muhammad I., Zhang, Min, Radominski, Sebastiao C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496806/
https://www.ncbi.nlm.nih.gov/pubmed/32476277
http://dx.doi.org/10.1111/1756-185X.13846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496806/
https://www.ncbi.nlm.nih.gov/pubmed/32476277
http://dx.doi.org/10.1111/1756-185X.13846

Ejemplares similares